Related Experiment Video

Updated: Jun 28, 2025

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

868

Clinical features of plastic bronchitis in children after congenital heart surgery

Li-Min Zhu1, Chun-Xiang Li1, Xiao-Lei Gong1

  • 1Department of Cardiac Intensive Care Unit, Shanghai Children' s Medical Center, Shanghai Jiaotong University School of Medicine, 1678 Dongfang Road, 200127, Shanghai, PR China.

Italian Journal of Pediatrics
|April 18, 2024
PubMed

Insights

Plastic bronchitis (PB) in children after congenital heart surgery (CHS) is linked to airway issues or right ventricular dysfunction. Treatment includes antibiotics, corticosteroids, and bronchoscopy, with ECMO for severe cases.

Area of Science:

  • Pediatric Cardiology
  • Pulmonology
  • Critical Care Medicine

Background:

  • Plastic bronchitis (PB) is a potential complication following congenital heart surgery (CHS).
  • Understanding PB's clinical features in this population is crucial for timely management.

Purpose of the Study:

  • To investigate the clinical characteristics of plastic bronchitis in pediatric patients post-congenital heart surgery.
  • To identify associated factors and treatment outcomes for PB in this cohort.

Main Methods:

  • Retrospective cohort study utilizing electronic medical records.
  • Inclusion of pediatric patients diagnosed with PB post-CHS between May 2016 and October 2021.
  • Analysis of clinical data, including bronchoscopy findings and treatment responses.

Main Results:

  • 68 children with PB post-CHS were analyzed, divided into airway abnormalities (32) and right ventricular dysfunction (36) groups.
  • Pathogens were identified in 41 patients; treatment involved antibiotics, corticosteroids, and budesonide inhalation.
  • 64 children showed symptom improvement; two required veno-arterial extracorporeal membrane oxygenation (ECMO) for refractory disease.

Conclusions:

  • Airway abnormalities and right ventricular dysfunction are key considerations for PB development post-CHS.
  • Core treatments include anti-infectives, corticosteroids, and optimizing right ventricular function, with fiberoptic bronchoscopy essential for diagnosis and therapy.
  • Extracorporeal membrane oxygenation (ECMO) serves as a critical life-saving intervention for severe, recurrent cases.
Abstract

Keywords:
Airway abnormalitiesChildrenCongenital heart surgeryFiberoptic bronchoscopyPlastic bronchitis

More Related Videos

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.9K
Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation07:28

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Published on: October 11, 2024

344

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.6K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
141